Bi-allelic variants in SHOC1 cause non-obstructive azoospermia with meiosis arrest in humans and mice. (29th April 2022)

• Record Type: Journal Article
• Authors: Wang, Weili; Meng, Lanlan; He, Jiaxin; Su, Lilan; Li, Yong; Tan, Chen; Xu, Xilin; Nie, Hongchuan; Zhang, Huan; Du, Juan; Lu, Guangxiu; Luo, Mengcheng; Lin, Ge; Tu, Chaofeng; Tan, Yue-Qiu
• Is Part Of: Molecular human reproduction. Volume 28:Number 6(2022)
• Publication Date: 2022-04-29
• Subjects: male infertility -- non-obstructive azoospermia -- meiosis arrest -- SHOC1 -- meiotic recombination; Human reproduction -- Molecular aspects -- Periodicals; Electronic journals; 612.6
• DOI: 10.1093/molehr/gaac015
• Languages: English
• ISSNs: 1360-9947

Abstract

Abstract: Meiosis is pivotal to gametogenesis and fertility. Meiotic recombination is a mandatory process that ensures faithful chromosome segregation and generates genetic diversity in gametes. Non-obstructive azoospermia (NOA) caused by meiotic arrest is a common cause of male infertility and has many genetic origins, including chromosome abnormalities, Y chromosome microdeletion and monogenic mutations. However, the genetic causes of the majority of NOA cases remain to be elucidated. Here, we report our findings of three Shortage in chiasmata 1 ( SHOC1 ) bi-allelic variants in three NOA patients, of which two are homozygous for the same loss-of-function variant (c.231_232del: p.L78Sfs*9), and one is heterozygous for two different missense variants (c.1978G>A: p.A660T; c.4274G>A: p.R1425H). Testicular biopsy of one patient revealed impairment of spermatocyte maturation. Both germ-cell-specific and general Shoc1 -knockout mice exhibited similar male infertility phenotypes. Subsequent analysis revealed comprehensive defects in homologous pairing and synapsis along with abnormal expression of DMC1, RAD51 and RPA2 in Shoc1- defective spermatocyte spreads. These findings imply that SHOC1 may have a presynaptic function during meiotic recombination apart from its previously identified role in crossover formation. Overall, our results provide strong evidence for the clinical relevance of SHOC1 mutations in patients with NOA and contribute to a deeper mechanistic understanding of the role of SHOC1 during meiotic recombination.